These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 8372797)
1. Nitrates versus angiotensin-converting enzyme inhibitors for congestive heart failure. Cohn JN Am J Cardiol; 1993 Sep; 72(8):21C-24C; discussion 24C-26C. PubMed ID: 8372797 [TBL] [Abstract][Full Text] [Related]
2. [Vasodilator agents in chronic heart failure: which is the best option?]. Corbalán R; Kunstmann S; Jalil J Rev Med Chil; 1993 Jan; 121(1):81-8. PubMed ID: 8235172 [TBL] [Abstract][Full Text] [Related]
3. The impact of beta-receptor blocker addition to high-dose angiotensin-converting enzyme inhibitor-nitrate therapy in heart failure. Levine TB; Levine AB; Keteyian SJ; Narins B Clin Cardiol; 1998 Dec; 21(12):899-904. PubMed ID: 9853182 [TBL] [Abstract][Full Text] [Related]
4. Congestive heart failure: what should be the initial therapy and why? Chatterjee K Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993 [TBL] [Abstract][Full Text] [Related]
5. The role of organic nitrates in the treatment of heart failure. Elkayam U; Karaalp IS; Wani OR; Tummala P; Akhter MW Prog Cardiovasc Dis; 1999; 41(4):255-64. PubMed ID: 10362348 [TBL] [Abstract][Full Text] [Related]
6. Treatment of infarct related heart failure: vasodilators other than ACE inhibitors. Cohn JN Cardiovasc Drugs Ther; 1994 Feb; 8(1):119-22. PubMed ID: 8086321 [TBL] [Abstract][Full Text] [Related]
7. Vasodilator therapy without converting-enzyme inhibition in congestive heart failure--usefulness and limitations. Remme WJ Cardiovasc Drugs Ther; 1989 Jun; 3(3):375-96. PubMed ID: 2487535 [TBL] [Abstract][Full Text] [Related]
8. Assessing the treatment of congestive heart failure: diuretics, vasodilators, and angiotensin-converting enzyme inhibitors. Chow MS Pharmacotherapy; 1993; 13(5 Pt 2):82S-87S. PubMed ID: 8233997 [TBL] [Abstract][Full Text] [Related]
9. New trends in the use of angiotensin converting enzyme inhibitors in chronic heart failure. Massie BM Am J Med; 1988 Apr; 84(4A):36-46. PubMed ID: 3064607 [TBL] [Abstract][Full Text] [Related]
15. [The impact of nitrates and mono-therapy and nitrates combined with angiotensin converting enzyme inhibitors on left ventricular remodeling and exercise capacity in patients after acute myocardial infarction]. Maciejewicz J; Maziarz A; Celibała R; Wiśniewski M; Wiśniewska M Przegl Lek; 2003; 60(2):80-4. PubMed ID: 12939852 [TBL] [Abstract][Full Text] [Related]
16. [The extension of heart failure therapy with vasodilators]. Assmann I Z Gesamte Inn Med; 1990 Jun; 45(12):352-6. PubMed ID: 2201132 [TBL] [Abstract][Full Text] [Related]
17. Treatment of congestive heart failure. de Denus S; Spinler SA JAMA; 2002 May; 287(17):2209; author reply 2210. PubMed ID: 11980513 [No Abstract] [Full Text] [Related]
18. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise. Chatterjee K; Massie B; Rubin S; Gelberg H; Brundage BH; Ports TA Am J Med; 1978 Jul; 65(1):134-45. PubMed ID: 99031 [TBL] [Abstract][Full Text] [Related]
19. Role of angiotensin converting enzyme inhibitors in patients with left ventricular dysfunction and congestive heart failure. McKelvie R; McConachie D; Yusuf S Eur Heart J; 1994 May; 15 Suppl B():9-13; discussion 26-30. PubMed ID: 8076660 [TBL] [Abstract][Full Text] [Related]
20. Overview of the treatment of heart failure. Cohn JN Am J Cardiol; 1997 Dec; 80(11A):2L-6L. PubMed ID: 9412537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]